Oral treatment with yolk antibodies for the prevention of C. albicans infections in chemotherapy treated children. A feasibility study

Author： Wilhelmson Maria   Carlander David   Kreuger Anders   Kollberg Hans   Larsson Anders  

Publisher： Taylor & Francis Ltd

ISSN： 1465-3443

Source： Food and Agricultural Immunology, Vol.16, Iss.1, 2005-03, pp. : 41-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroral immunotheraphy with yolk antibodies for the prevention and treatment of enteric infections

By Carlander David   Kollberg Hans   Wejåker Per-Erik   Larsson Anders  

Immunologic Research, Vol. 21, Iss. 1, 2000-02 ,pp. : 1-6

Humana Press, Inc

Access to resources Recommend Favorite

Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double‐blind placebo‐controlled study

By  

Immunity, Inflammation And Disease, Vol. 3, Iss. 2, 2015-06 ,pp. : 45-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral mucositis in cancer treatment: Natural history, prevention and treatment (Review)

By        

Molecular and Clinical Oncology, Vol. 2, Iss. 3, 2014-01 ,pp. : 337-340

Spandidos Publications

Access to resources Recommend Favorite

Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: A randomized case-controlled study

By Abdelrazik Nabil   Fouda Manal  

Hematology, Vol. 12, Iss. 6, 2007-12 ,pp. : 533-541

Maney Publishing

Access to resources Recommend Favorite

Killer antibodies in fungal infections

By Conti S.   Magliani W.   Fisicaro P.   Dieci E.   Arseni S.   Salati A.   Polonelli L.  

Research in Immunology, Vol. 149, Iss. 4, 1998-05 ,pp. : 334-343

Elsevier

Access to resources Recommend Favorite